BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Abul Khair SB, Dhanushkodi NR, Ardah MT, Chen W, Yang Y, Haque ME. Silencing of Glucocerebrosidase Gene in Drosophila Enhances the Aggregation of Parkinson's Disease Associated α-Synuclein Mutant A53T and Affects Locomotor Activity. Front Neurosci 2018;12:81. [PMID: 29503608 DOI: 10.3389/fnins.2018.00081] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Nitta Y, Sugie A. Studies of neurodegenerative diseases using Drosophila and the development of novel approaches for their analysis. Fly (Austin) 2022;16:275-98. [PMID: 35765969 DOI: 10.1080/19336934.2022.2087484] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Ma M, Moulton MJ, Lu S, Bellen HJ. 'Fly-ing' from rare to common neurodegenerative disease mechanisms. Trends Genet 2022:S0168-9525(22)00080-4. [PMID: 35484057 DOI: 10.1016/j.tig.2022.03.018] [Reference Citation Analysis]
3 Smith L, Schapira AHV. GBA Variants and Parkinson Disease: Mechanisms and Treatments. Cells 2022;11:1261. [DOI: 10.3390/cells11081261] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
4 Suzuki M, Sango K, Nagai Y. Roles of α-Synuclein and Disease-Associated Factors in Drosophila Models of Parkinson's Disease. Int J Mol Sci 2022;23:1519. [PMID: 35163450 DOI: 10.3390/ijms23031519] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Valek L, Tran B, Wilken-Schmitz A, Trautmann S, Heidler J, Schmid T, Brüne B, Thomas D, Deller T, Geisslinger G, Auburger G, Tegeder I. Prodromal sensory neuropathy in Pink1-/- SNCAA53T double mutant Parkinson mice. Neuropathol Appl Neurobiol 2021. [PMID: 33974284 DOI: 10.1111/nan.12734] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Vos M, Klein C. The Importance of Drosophila melanogaster Research to UnCover Cellular Pathways Underlying Parkinson's Disease. Cells 2021;10:579. [PMID: 33800736 DOI: 10.3390/cells10030579] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Klatt‐schreiner K, Valek L, Kang J, Khlebtovsky A, Trautmann S, Hahnefeld L, Schreiber Y, Gurke R, Thomas D, Wilken‐schmitz A, Wicker S, Auburger G, Geisslinger G, Lötsch J, Pfeilschifter W, Djaldetti R, Tegeder I. High Glucosylceramides and Low Anandamide Contribute to Sensory Loss and Pain in Parkinson's Disease. Mov Disord 2020;35:1822-33. [DOI: 10.1002/mds.28186] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
8 Sanyal A, Novis HS, Gasser E, Lin S, LaVoie MJ. LRRK2 Kinase Inhibition Rescues Deficits in Lysosome Function Due to Heterozygous GBA1 Expression in Human iPSC-Derived Neurons. Front Neurosci 2020;14:442. [PMID: 32499675 DOI: 10.3389/fnins.2020.00442] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
9 Correia Guedes L, Mestre T, Outeiro TF, Ferreira JJ. Are genetic and idiopathic forms of Parkinson's disease the same disease? J Neurochem 2020;152:515-22. [PMID: 31643079 DOI: 10.1111/jnc.14902] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
10 Bellomo G, Paciotti S, Gatticchi L, Parnetti L. The Vicious Cycle Between α ‐Synuclein Aggregation and Autophagic‐Lysosomal Dysfunction. Mov Disord 2020;35:34-44. [DOI: 10.1002/mds.27895] [Cited by in Crossref: 25] [Cited by in F6Publishing: 35] [Article Influence: 8.3] [Reference Citation Analysis]
11 Aryal B, Lee Y. Disease model organism for Parkinson disease: Drosophila melanogaster. BMB Rep 2019;52:250-8. [PMID: 30545438 [PMID: 30545438 DOI: 10.5483/bmbrep.2019.52.4.204] [Cited by in Crossref: 16] [Article Influence: 5.3] [Reference Citation Analysis]
12 Do J, McKinney C, Sharma P, Sidransky E. Glucocerebrosidase and its relevance to Parkinson disease. Mol Neurodegener 2019;14:36. [PMID: 31464647 DOI: 10.1186/s13024-019-0336-2] [Cited by in Crossref: 67] [Cited by in F6Publishing: 101] [Article Influence: 22.3] [Reference Citation Analysis]
13 Siddique YH, Naz F, Rahul, Rashid M, Tajuddin. Effect of Majun Baladur on life span, climbing ability, oxidative stress and dopaminergic neurons in the transgenic Drosophila model of Parkinson's disease. Heliyon 2019;5:e01483. [PMID: 31011645 DOI: 10.1016/j.heliyon.2019.e01483] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Czubowicz K, Jęśko H, Wencel P, Lukiw WJ, Strosznajder RP. The Role of Ceramide and Sphingosine-1-Phosphate in Alzheimer's Disease and Other Neurodegenerative Disorders. Mol Neurobiol 2019;56:5436-55. [PMID: 30612333 DOI: 10.1007/s12035-018-1448-3] [Cited by in Crossref: 68] [Cited by in F6Publishing: 62] [Article Influence: 22.7] [Reference Citation Analysis]
15 Lin G, Wang L, Marcogliese PC, Bellen HJ. Sphingolipids in the Pathogenesis of Parkinson's Disease and Parkinsonism. Trends Endocrinol Metab 2019;30:106-17. [PMID: 30528460 DOI: 10.1016/j.tem.2018.11.003] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 9.3] [Reference Citation Analysis]
16 Nagoshi E. Drosophila Models of Sporadic Parkinson's Disease. Int J Mol Sci 2018;19:E3343. [PMID: 30373150 DOI: 10.3390/ijms19113343] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 5.5] [Reference Citation Analysis]
17 Franco R, Sánchez-Arias JA, Navarro G, Lanciego JL. Glucocerebrosidase Mutations and Synucleinopathies. Potential Role of Sterylglucosides and Relevance of Studying Both GBA1 and GBA2 Genes. Front Neuroanat 2018;12:52. [PMID: 30002620 DOI: 10.3389/fnana.2018.00052] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]